Clinical, immunopathologic, and therapeutic considerations of inflammatory myopathies

Clinical Neuropharmacology

Volumn 15, Issue 5, 1992, Pages 327-351

  Dalakas, M C ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Dermatomyositis; Inclusion body myositis; Polymyositis

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; MUSCLE ENZYME; PREDNISONE;

ANTIBODY BLOOD LEVEL; CLINICAL FEATURE; DERMATOMYOSITIS; DIET; ELECTROMYOGRAPHY; ENZYME BLOOD LEVEL; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE IRRADIATION; MUSCLE BIOPSY; MYOPATHY; MYOSITIS; ORAL DRUG ADMINISTRATION; PATHOGENESIS; POLYMYOSITIS; PRIORITY JOURNAL; RETROVIRUS; REVIEW;

EID: 0026699848     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199210000-00001     Document Type: Review

References (0)